(3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-one

CAS: 879551-04-9

Ref. 3D-MF44944

Produktinformation

• Name: (3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-one
• Synonyme: (2R) -2-Deoxy-2-fluoro-2-methyl-D- erythro- pentonic acid gamma-lactone2- Deoxy- 2- fluoro- 2- C- methyl- d- ribono- gamma- lactone (3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyl-dihydrofuran-2(3H)-one, (2R)-2-Deoxy-2-fluoro-2-methyl-<span class="text-smallcaps">D</span>-erythro-pentonic acid γ-lactone, (3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyldihydro-2(3H)-furanone, 3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-one, <span class="text-smallcaps">D</span>-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, (2R)-, D-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, ??-lactone, D-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, gamma-lactone
• CAS: 879551-04-9

Beschreibung

(3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-one is a nucleoside that has been synthesized and characterized by x-ray crystallographic analysis. It is an analog of the nucleoside fluorouracil which has been fluorinated at the 5 position of the oxo group. The crystal structure of (3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-one was determined using x ray crystallography to be a lactone with an anhydrous form. This compound is currently being investigated as a potential drug candidate for cancer treatment.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 164.13 g/mol
• Formel: C₆H₉FO₄
• Reinheit: Min. 95%